1. Home
  2. SLGL vs XPL Comparison

SLGL vs XPL Comparison

Compare SLGL & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • XPL
  • Stock Information
  • Founded
  • SLGL 1997
  • XPL 1984
  • Country
  • SLGL Israel
  • XPL United States
  • Employees
  • SLGL N/A
  • XPL N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • XPL Precious Metals
  • Sector
  • SLGL Health Care
  • XPL Basic Materials
  • Exchange
  • SLGL Nasdaq
  • XPL Nasdaq
  • Market Cap
  • SLGL 69.1M
  • XPL 62.5M
  • IPO Year
  • SLGL 2018
  • XPL N/A
  • Fundamental
  • Price
  • SLGL $33.66
  • XPL $0.61
  • Analyst Decision
  • SLGL Strong Buy
  • XPL Strong Buy
  • Analyst Count
  • SLGL 1
  • XPL 2
  • Target Price
  • SLGL $50.00
  • XPL $1.20
  • AVG Volume (30 Days)
  • SLGL 11.7K
  • XPL 606.8K
  • Earning Date
  • SLGL 11-07-2025
  • XPL 10-31-2025
  • Dividend Yield
  • SLGL N/A
  • XPL N/A
  • EPS Growth
  • SLGL N/A
  • XPL N/A
  • EPS
  • SLGL N/A
  • XPL N/A
  • Revenue
  • SLGL $23,931,000.00
  • XPL N/A
  • Revenue This Year
  • SLGL N/A
  • XPL N/A
  • Revenue Next Year
  • SLGL N/A
  • XPL N/A
  • P/E Ratio
  • SLGL N/A
  • XPL N/A
  • Revenue Growth
  • SLGL 264.86
  • XPL N/A
  • 52 Week Low
  • SLGL $4.01
  • XPL $0.54
  • 52 Week High
  • SLGL $52.26
  • XPL $0.90
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 45.02
  • XPL 39.02
  • Support Level
  • SLGL $30.85
  • XPL $0.59
  • Resistance Level
  • SLGL $39.00
  • XPL $0.62
  • Average True Range (ATR)
  • SLGL 2.87
  • XPL 0.04
  • MACD
  • SLGL -1.25
  • XPL -0.01
  • Stochastic Oscillator
  • SLGL 22.17
  • XPL 11.43

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

Share on Social Networks: